Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
life sciences
national blog main
startups
4
×
boston blog main
clinical trials
deals
fda
ipo
new york blog main
new york top stories
san francisco blog main
san francisco top stories
biogen
boston top stories
boulder/denver blog main
boulder/denver top stories
cancer
covid-19
deerfield management
detroit blog main
detroit top stories
europe blog main
europe top stories
gilead sciences
indiana blog main
indiana top stories
investing
medical device
melinta therapeutics
national
national top stories
novartis
oric pharmaceuticals
raleigh-durham blog main
raleigh-durham top stories
renaissance capital
san diego blog main
san diego top stories
seattle blog main
What
ipo
4
×
bio
biotech
covid
developing
markets
medicines
new
public
roundup
way
acquisitions
activity
announced
approvals
biogen
boost
ceo
clamped
collabs
companies
company
daniel
deal
debut
delays
economic
fast
fda
followed
genomics
gilead
gilead’s
haul
help
including
introduce
isn’t
late
led
Language
unset
4
×
Current search:
startups
×
unset
×
ipo
×
@xconomy.com
4 years ago
Lyra Therapeutics IPO Raises $56M for Tests of Tech for Runny Noses
@xconomy.com
4 years ago
Bio Roundup: Fast FDA Approvals, Biogen Delays, ORIC’s IPO & More
@xconomy.com
4 years ago
Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More
@xconomy.com
4 years ago
SpringWorks and Satsuma Boost This Week’s Biotech IPO Haul to $595M